首页> 外文期刊>Medical science monitor : >Incidence of complications of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication
【24h】

Incidence of complications of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication

机译:根除Hp时代幽门螺杆菌(Hp)感染和/或使用NSAID患者的消化性溃疡并发症发生率

获取原文
获取外文期刊封面目录资料

摘要

Background: Hp and NSAID are considered as major pathogens in peptic ulcerations and their complications but little is known about the incidence of ulcers and their complications following widespreaduse of Hp eradication. The aims of the study were: 1) to analyze incidence of ulcers and their complications, bleeding and perforations at time when the Hp eradication has been used in ulcer therapy, and 2) to assess the impact of Hp infection and NSAID use on the incidenceof ulcers and complications.Material/Methods: From 1996 to 2001, 381 patients with complications of peptic ulcers were admitted to the emergency surgery, including 273 patients with bleeding ulcers and 108 with perforations out of a sample of 6515 dyspeptic patients examined with upper endoscopy and 13C-urea breath test (UBT).Results: The rate of ulcer bleeding and perforations, remained relatively constant throughout the study period. NSAID use in that group increased form 15.8% in 1999 to 19.4% in 2001. Theincidence of Hp in patients with complications assessed by UBT or CLO was 76.7%, while the incidence of Hp in 7920 patients ranged form 72.8% in 1996 to 53.8% in 2001. There were 1940 (29.7%) patients with duodenal and/or gastric ulcer diagnosed by upper gastroscopy.The decline in the prevalence of peptic ulcer from about 44% to 8% occurred over the same time. A slight increase in the number of ulcer resulting from NSAID use was observed so was the number of ulcers without Hp or NSAID (idiopathic).Conclusions: Despite decreased Hp prevalence, the incidence of ulcers complications remained unchanged probably due to increased use of NSAID and the appearance of idiopathic ulcers.
机译:背景:幽门螺杆菌和非甾体抗炎药被认为是消化性溃疡及其并发症的主要病原体,但是对于广泛使用根除幽门螺杆菌的溃疡及其并发症的发病率知之甚少。该研究的目的是:1)分析在溃疡治疗中使用Hp根除时溃疡的发生率及其并发症,出血和穿孔,以及2)评估Hp感染和NSAID使用对溃疡发生率的影响。材料/方法:从1996年至2001年,在6515例消化不良患者的上消化道内镜检查和胃镜检查中,有381例消化性溃疡并发症的患者被纳入急诊手术,其中包括273例溃疡性溃疡和108例穿孔的穿孔。结果:13C-尿素呼气试验(UBT)。在整个研究期间,溃疡出血和穿孔的发生率保持相对恒定。在该组中,NSAID的使用率从1999年的15.8%增加到2001年的19.4%。通过UBT或CLO评估的并发症患者中Hp的发生率为76.7%,而7920名患者中Hp的发生率从1996年的72.8%到53.8%。在2001年,有1940例(29.7%)的经上胃镜检查诊断为十二指肠和/或胃溃疡的患者。消化性溃疡的患病率从大约44%下降到8%。结论:尽管Hp患病率下降,但溃疡并发症的发生率仍未改变,这可能是由于增加了NSAID和NPS的使用所致;而没有Hp或NSAID(特发性)的溃疡则有所增加。特发性溃疡的出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号